Akso Net Income from 2010 to 2026
| AHG Stock | USD 1.60 0.14 9.59% |
Net Loss | First Reported 2015-06-30 | Previous Quarter -67.2 M | Current Value -67.2 M | Quarterly Volatility 22.8 M |
Check Akso Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akso Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Selling General Administrative of 4 M or Selling And Marketing Expenses of 144 K, as well as many indicators such as Price To Sales Ratio of 30.39, Dividend Yield of 0.088 or PTB Ratio of 1.85. Akso financial statements analysis is a perfect complement when working with Akso Health Valuation or Volatility modules.
Akso | Net Income | Build AI portfolio with Akso Stock |
The Net Income trend for Akso Health Group offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Akso Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Akso Health's Net Income Growth Pattern
Below is the plot of the Net Income of Akso Health Group over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Akso Health Group financial statement analysis. It represents the amount of money remaining after all of Akso Health Group operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Akso Health's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Akso Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (135.47 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Akso Net Income Regression Statistics
| Arithmetic Mean | (24,951,970) | |
| Coefficient Of Variation | (216.69) | |
| Mean Deviation | 41,544,491 | |
| Median | (350,171) | |
| Standard Deviation | 54,067,604 | |
| Sample Variance | 2923.3T | |
| Range | 200.5M | |
| R-Value | (0.67) | |
| Mean Square Error | 1734.2T | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | (7,133,176) | |
| Total Sum of Squares | 46772.9T |
Akso Net Income History
Other Fundumenentals of Akso Health Group
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Akso Health Net Income component correlations
About Akso Health Financial Statements
Akso Health stakeholders use historical fundamental indicators, such as Akso Health's Net Income, to determine how well the company is positioned to perform in the future. Although Akso Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akso Health's assets and liabilities are reflected in the revenues and expenses on Akso Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akso Health Group. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -121.9 M | -115.8 M | |
| Net Loss | -121.9 M | -115.8 M | |
| Net Loss | -1.2 M | -1.3 M | |
| Net Loss | (0.54) | (0.57) | |
| Net Income Per E B T | 0.73 | 1.43 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Akso Health Correlation against competitors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Akso have expansion opportunities? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Akso Health demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.48) | Revenue Per Share | Quarterly Revenue Growth 4.158 | Return On Assets | Return On Equity |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Akso Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Akso Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Akso Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.